Theriva Biologics Inc. (TOVX)

Theriva Biologics Inc. (TOVX) is a Biotechnology company in the Healthcare sector listed on the NYSE MKT.

As of Oct 23, 2026: market cap $9.9M; returns 1 day +3.2%, 1 week -5.7%, 1 year -42.4%.

Theriva Biologics is a clinical-stage pharmaceutical company focused on developing a novel oncolytic adenovirus platform and gut-microbiome therapeutics for high-mortality cancers and related complications. The company operates as a pre-revenue entity, with its economic value centered on its pipeline assets rather than product sales.

Groups TOVX belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Pharmaceuticals
• Oncology
• Cancer Therapeutics
• Biologics
• Clinical Stage
• Pancreatic Cancer
• Digestive Health
• Ophthalmology

TOVX financial model: income statement, cash flow and balance sheet